U.S. security panel says China is overtaking America in commercial brain implants

A U.S. congressional commission warned that China is overtaking American efforts to commercialize brain-computer interfaces, after Beijing this spring issued what is widely described as the world's first market approval for an implantable BCI. The National Security Commission on Emerging Biotechnology said U.S. development is being passed on manufacturing, data, and clinic access, with effects that could reach military systems and AI models trained on brain recordings.